NASDAQ:IMMX

Immix Biopharma Stock Forecast

etoro logo Buy IMMX
*Your capital is at risk
$10.13
+0.410 (+4.22%)
At Close: Aug 10, 2026

Should you buy IMMX stock?

Last updated:

Based on market data through , StockInvest.us rates Immix Biopharma, Inc. (IMMX) as a Buy Candidate with a technical score of 2.98 on its -10 to +10 scale. This is an upgrade from Sell in the previous daily evaluation.

  • Buy signal since
  • Price since signal Flat 0.00%
  • 3-month trend forecast Up 4.07%
  • Buy Candidate 2.98
AI Analysis AI Analysis of IMMX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add IMMX to Watchlist?
Some Reasons Why To Add IMMX:
  • +336.6% price growth over the last year
  • +86.6% YTD performance
  • Lower volatility than the market (beta 0.11)
PDF

Stronger technical forecast for Immix Biopharma, Inc. stock price after Monday trading
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Aug 10, 2026

The Immix Biopharma, Inc. stock price gained 4.22% on the last trading day (Monday, 10th Aug 2026), rising from $9.72 to $10.13. During the last trading day the stock fluctuated 6.83% from a day low at $9.66 to a day high of $10.32. The price has risen in 6 of the last 10 days and is up by 16.57% over the past 2 weeks. Volume fell on the last day by -5 thousand shares and in total, 2 million shares were bought and sold for approximately $16.21 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 4.07% during the next 3 months and, with a 90% probability hold a price between $8.54 and $12.70 at the end of this 3-month period.

IMMX Signals & Forecast

Mostly positive signals in the chart today. The Immix Biopharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $9.36 and $9.78. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 23.99%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Immix Biopharma, Inc. stock

Immix Biopharma, Inc. finds support from accumulated volume at $9.98 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.660 between high and low, or 6.83%. For the last week, the stock has had daily average volatility of 7.86%.

Our recommended stop-loss: $9.79 (-3.38%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 8 days ago.)

Trading Expectations (IMMX) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Immix Biopharma, Inc. to open at $10.04, and during the day (based on 14 day Average True Range), to move between $9.76 and $10.50, which gives a possible trading interval of +/-$0.744 (+/-7.62%) up or down from last closing price. If Immix Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 7.62% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $9.98 (1.48%) than the resistance at $10.49 (3.55%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Immix Biopharma, Inc. will release earnings BMO on Friday, August 14, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.170. We will update the financials statements for Immix Biopharma, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 7.63% in the first trading day after earnings release.

Is Immix Biopharma, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Immix Biopharma, Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.978 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $10.04 ( 0.92%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

IMMX Performance

Trading levels for IMMX

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 10.70 5.59%
R2 10.44 3.11%
R1 10.29 1.57%
Price 10.13
S1 9.78 -3.41%
S2 9.63 -4.95%
S3 9.38 -7.44%

Accumulated Volume Support & Resistance Levels

Level Price
R3 12.02 18.66%
R2 11.00 8.59%
R1 10.49 3.55%
Price 10.13
S1 9.98 -1.48%
S2 8.72 -13.92%
S3 8.67 -14.41%

FAQ

What is the symbol for Immix Biopharma, Inc. Stock and on which exchange is it traded?
The symbol for Immix Biopharma, Inc. is IMMX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Immix Biopharma, Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Immix Biopharma, Inc. (IMMX) as a Buy Candidate with a technical score of 2.98 on its -10 to +10 scale. This is an upgrade from Sell in the previous daily evaluation. Since the Buy signal began on Aug 10, 2026, the price has remained flat. The current 3-month trend forecast projects a rise of 4.07%.

How to buy Immix Biopharma, Inc. Stock?
Immix Biopharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Immix Biopharma, Inc. Stock.

What's the current price of Immix Biopharma, Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an Immix Biopharma, Inc. (IMMX) share was $10.13.

What is the 52-week high and low for Immix Biopharma, Inc. Stock?
The 52-week high for Immix Biopharma, Inc. Stock is $12.14 and the 52-week low is $1.94.

What is the market capitalization of Immix Biopharma, Inc. Stock?
As of the Aug 10, 2026, the market capitalization of Immix Biopharma, Inc. is 551.091M.

When is the next earnings date for Immix Biopharma, Inc.?
The upcoming earnings date for Immix Biopharma, Inc. is Aug 14, 2026.
Click to get the best stock tips daily for free!
ABOUT IMMIX BIOPHARMA, INC.
Immix Biopharma
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the tr...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE